Ranibizumab: a medical treatment that requires surgical administration
- 14 April 2011
- journal article
- Published by Springer Nature in Eye
- Vol. 25 (4) , 399-401
- https://doi.org/10.1038/eye.2011.3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- HIGH-MOLECULAR-WEIGHT AGGREGATES IN REPACKAGED BEVACIZUMABRetina, 2010
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab: Phase III Clinical Trial ResultsOphthalmology Clinics of North America, 2006
- Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration: Two-Year Safety Results of the Two Prospective, Multicenter, Controlled Clinical TrialsOphthalmology, 2006
- Global data on visual impairment in the year 2002.2004
- EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONSRetina, 2004
- The Role of Vascular Endothelial Growth Factor in AngiogenesisActa Haematologica, 2001
- VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 å resolution and mutational analysis of the interfaceStructure, 1998
- Age-Related Macular Degeneration and Blindness due to Neovascular MaculopathyArchives of Ophthalmology (1950), 1984